dipeptidase-1 targeting antibody program (Arch BioPartners)

N/A

Report date: 2025/03/19 09:01:03

Base Information

Drug Namedipeptidase-1 targeting antibody program (Arch BioPartners)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionRenal dipeptidase inhibitors
TargetsRenal dipeptidase
Therapy Area/IndicationsRenal InsufficiencyNephritisKidney Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArch Biopartners Inc
China Registration ClassN/A

Develop Information

Active CompaniesArch Biopartners Inc
Inactive CompaniesN/A
Active IndicationsRenal InsufficiencyNephritisKidney Diseases +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A